Medical Tech Company Owner Charged in COVID-19 Testing Fraud Scheme
- June 12, 2020
Mark Schena, president of Arrayit Corporation, a California-based medical technology company, has been charged for his alleged participation in schemes to mislead investors, to manipulate the company’s stock price, and to conspire to commit health care fraud in connection with the submission of over $69 million in false and fraudulent claims for allergy and COVID-19 testing, the Department of Justice announced June 9.
ARTICLE TAGS
You must be logged in to access this content.